Biotech · Private company
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Track this companyFree. Adds Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- Best Available TherapyPhase 3 · Urinary Tract Infection ComplicatedClinicalTrials.gov · fetched Nov 12, 2026
- VabomerePhase 3 · Urinary Tract Infection ComplicatedClinicalTrials.gov · fetched Nov 12, 2026
- AntibioticsPhase 2 · Acute PyelonephritisClinicalTrials.gov · fetched Nov 12, 2026
- Meropenem-VaborbactamPhase 2 · Acute PyelonephritisClinicalTrials.gov · fetched Nov 12, 2026
- meropenem-vaborbactamPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MoxifloxacinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- VabomerePhase 1 · Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- Minocycline IVGram-Negative Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute PyelonephritisPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 3, 2025ClinicalTrials.gov NCT06672978 · fetched Nov 12, 2026
- Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy VolunteersPHASE1 · COMPLETED · started May 1, 2018ClinicalTrials.gov NCT03564158 · fetched Nov 12, 2026
- A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World SettingCOMPLETED · started Oct 11, 2017ClinicalTrials.gov NCT03160040 · fetched Nov 12, 2026
- Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial InfectionsPHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02687906 · fetched Nov 12, 2026
- Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in AdultsPHASE3 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02168946 · fetched Nov 12, 2026